The purpose of this study is to test the safety and efficacy of a new drug (CSL112, also known as Apolipoprotein A-I) in participants with acute coronary syndrome.
Visit ClinicalTrials.gov for more information.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.